| Sep 20 |
Apellis European Rejection for Vision Treatment Dents Revenue Growth, Stock Performance, Wedbush Says
|
| Sep 20 |
Apellis Stock Hammered After Eye Drug Gets A Third European Rejection
|
| Sep 20 |
Apellis Pharmaceuticals declines afters CHMP's third negative opinion on Syfovre
|
| Sep 20 |
Apellis eye drug again turned back in Europe
|
| Sep 20 |
Apellis Receives Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU Following Re-Examination
|
| Sep 14 |
Apellis Pharmaceuticals, Inc. (APLS): Among Hedge Funds’ Top Biotech Stock Picks
|
| Sep 13 |
Analyst Scoreboard: 15 Ratings For Apellis Pharmaceuticals
|
| Sep 6 |
Why Is SpringWorks Therapeutics (SWTX) Up 11.7% Since Last Earnings Report?
|
| Sep 6 |
Exploring 3 High Growth Tech Stocks in the United States
|
| Sep 5 |
Acadia (ACAD) Up 10% Since Last Earnings Report: Can It Continue?
|
